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The RPN4 (SON1, UFD5) protein of the yeast Saccharomyces cer-
evisiae is required for normal levels of intracellular proteolysis.
RPN4 is a transcriptional activator of genes encoding proteasomal
subunits. Here we show that RPN4 is required for normal levels of
these subunits. Further, we demonstrate that RPN4 is extremely
short-lived (t1/2 ’2 min), that it directly interacts with RPN2, a
subunit of the 26S proteasome, and that rpn4D cells are perturbed
in their cell cycle. The degradation signal of RPN4 was mapped to
its N-terminal region, outside the transcription–activation domains
of RPN4. The ability of RPN4 to augment the synthesis of protea-
somal subunits while being metabolically unstable yields a nega-
tive feedback circuit in which the same protein up-regulates the
proteasome production and is destroyed by the assembled active
proteasome.
proteolysis u ubiquitin u N-end rule u UFD pathway u cell cycle
The Saccharomyces cerevisiae RPN4 gene (its earlier namesare SON1 and UFD5) (1) was originally identified through
mutant rpn4 alleles that suppressed the growth defect of sec63–
101 cells, which bore a temperature-sensitive (ts) variant of
SEC63, an essential component of the protein translocation
channel in the endoplasmic reticulum membrane (2). More
recent studies have shown that mutations in RPN4 inhibit the
degradation of normally short-lived proteins that are targeted by
the N-end rule pathway, by the ubiquitinyfusionydegradation
(UFD) pathway, and apparently also by other pathways of the
ubiquitin (Ub)–proteasome system (3, 4). These findings sug-
gested that the ability of rpn4 mutations to suppress the condi-
tional lethality of sec63–101 may stem from stabilization of the
mutant but partially active SEC63–101 against degradation at
nonpermissive temperature.
Regulated proteolysis by the Ubyproteasome system plays
essential roles in the cell cycle, differentiation, stress responses,
and many other processes (5–7). Ub is a 76-residue protein whose
covalent conjugation to other proteins marks these proteins for
degradation by the 26S proteasome, an ATP-dependent multi-
subunit protease. Ub conjugation involves the formation of a
thioester between the C terminus of Ub and a specific cysteine
of the Ub-activating (E1) enzyme. The Ub moiety of E1;Ub
thioester is transesterified to a cysteine in one of several Ub-
conjugating (E2) enzymes. The Ub moiety of E2;Ub thioester
is conjugated via the isopeptide bond to the «-amino group of
either a substrate’s Lys residue or a Lys residue of another Ub
moiety, the latter reaction resulting in a substrate-linked
multi-Ub chain (7, 8). Most E2 enzymes function in complexes
with proteins called E3 (9–11). The functions of E3s include the
initial recognition of degradation signals (degrons) in substrate
proteins, with different E3s recognizing different classes of
degrons (12–14). The E2–E3 complexes, referred to as Ub ligases
(this term is also used to denote E3s alone), mediate the
formation of substrate-linked multi-Ub chains (15, 16). Ubiqui-
tylated substrates are processively degraded by the 26S protea-
some, which consists of the 20S core proteasome and two 19S
particles (17–19). In vivo, the 20S proteasome exists in complexes
with either the 19S particle or the 11S particle (of a distinct
protein composition). The latter particle stimulates the pepti-
dase but not the protease activity of the 20S proteasome (18).
One 19S and one 11S particle can be bound to each end of the
same 20S proteasome, a configuration of likely physiological
significance (20, 21). The 19S particle mediates the binding and
ATP-dependent unfolding of a substrate protein before its
transfer to the interior of the 20S core (17). The biogenesis of the
20S proteasome has been analyzed in some detail (ref. 22 and
refs. therein). Most, if not all, of the genes encoding the
stoichiometrically present subunits of the S. cerevisiae 26S pro-
teasome have been identified (1, 23–26), but regulation of these
genes remains to be understood.
Consistent with the effects of rpn4 mutations on Ubyprotea-
some-dependent proteolysis, RPN4 was reported to cofraction-
ate with a partially purified 26S proteasome (27). However,
RPN4 was not detected among proteasomal subunits in other
analyses of purified 26S proteasomes (23, 25). Recent work
identified a specific sequence motif in the promoters of yeast
proteasomal genes and demonstrated that RPN4 binds to this
motif and functions as a transcriptional activator of the motif-
containing promoters (28).
In the present study, we showed that RPN4 is required for
normal levels of proteasomal subunits in the cell. Further, we
found that RPN4 is an extremely short-lived protein, that it
directly interacts with at least one specific subunit of the 26S
proteasome, and that cells lacking RPN4 are perturbed in their
progression through post-G1 phases of the cell cycle. We also
characterized the degron of RPN4, locating it outside the
putative transcription-activating domains. Our findings indicate
that the ability of RPN4 to augment the synthesis of proteasomal
subunits while being metabolically unstable yields a negative
feedback circuit in which the intracellular proteolysis is up-
regulated by a protein that is destroyed by the assembled active
proteasome.
Materials and Methods
Strains, Plasmids, and b-Galactosidase (bgal) Assay. The S. cerevisiae
strains used were EJY140 (MATa trp1-D63 ura3–52 his3-D200
leu2–3, 112 lys2–801 rpn4D::LEU2); JD52 (MATa trp1-D63
ura3–52 his3-D200 leu2–3, 112 lys2– 801); AVY302
(rpn2D::URA3 derivative of JD52); Y791 (MATa cim5–1 ura3–52
his3-D200 leu2D1); MHY501 (MATa trp1–1 ura3–52 his3-D200
leu2–3, 112 lys2–801); MHY1409 (MATa trp1–1 ura3–52 his3-
D200 leu2–3, 112 lys2–801 uba1–2) (3, 29, 37). RPN1 containing
its promoter region was isolated as a suppressor of the toxicity
Abbreviations: ts, temperature sensitive; Ub, ubiquitin; bgal, E. coli b -galactosidase; UFD,
ub/fusion/degradation.
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of overexpressed N-end rule pathway (30). PRE6 (containing its
promoter region) and the ORF of RPN4 were amplified by PCR
from total DNA of S. cerevisiae YPH500. All constructs were
verified by DNA sequencing. RPN1 and PRE6 (bearing their
promoter regions) were subcloned into the low-copy vector
pRS313 (31), yielding p313RPN1 and p313PRE6. The RPN4
ORF was subcloned into the low-copy vector pRS314CUP1
derived from pRS314 (31), yielding p314CUP1RPN4, in which
RPN4 was expressed from the PCUP1 promoter. For immuno-
blotting and immunoprecipitation, the flag epitope was added to
the C termini of RPN1, PRE6, and RPN4. Alternatively, the N
terminus of RPN4 was extended with the ha epitope (32). For
GST-pulldown assays, the ORFs of RPN1, RPN2, RPN9, RPN10,
and RPN12 were fused in frame to the 39-end of the GST-coding
sequence in pGEX-4T-3 (Amersham Pharmacia). The C-
terminally f lag-tagged derivative of RPN4 was subcloned into
pET-11c (Novagen). Escherichia coli BL21 (DE3) was used to
express GST fusions, as well as RPN4-flag. The E. coli lacZ gene
encoding bgal lacking the first eight residues was amplified by
PCR, by using pMC1871 (Amersham Pharmacia) as a template.
This bgal was expressed as a fusion to the C terminus of
RPN41–151 from the PCUP1 promoter and pRS315 vector (31).
UbK48R,G76A was expressed from the PCUP1 promoter and a
high-copy vector (33). Arg-bgal, derived from Ub-Arg-bgal, was
expressed from the PGAL1 promoter and a high-copy vector (3).
The activity of bgal in yeast extracts, from cultures at A600 of
0.8–1.0, was determined as described (32).
Immunoblotting, Pulse–Chase, and GST-Pulldown Assays. S. cerevisiae
transformants were grown to OD600 of 0.8–1.0, harvested, and
resuspended in lysis buffer (1% Triton X-100y0.15 M NaCly1
mM EDTAy50 mM Na-Hepes, pH 7.5) containing 13 protease
inhibitor mix (Boehringer Mannheim), and lysed by vortexing
with glass beads. Equal amounts of extracts were separated by
SDSyPAGE, followed by immunoblotting with monoclonal anti-
f lag antibody (Sigma) or anti-ha antibody (Covance, Berkeley,
CA). SDSyPAGE in 6, 8, and 12% gels was used with, respec-
tively, RPN1-flag, RPN4-flag or ha-RPN4, and PRE6-flag or
truncated RPN4 proteins. Pulse–chase procedures were as
described (30). Briefly, 10-ml cultures (OD600 of 0.8–1.2) of
wild-type, rpn2D, cim5–1, and uba1–2 S. cerevisiae in SD media
(30) containing 0.2 mM CuSO4 were labeled for 5 min with 0.15
mCi of [35S]methionineycysteine (EXPRESS, New England
Nuclear). Labeled cells were pelleted, resuspended in 0.8 ml of
lysis buffer, and lysed as above. The extracts were centrifuged at
12,000 3 g for 10 min, and supernatants containing equal
amounts of CCl3COOH-insoluble 35S were used for immuno-
precipitation with anti-f lag, anti-ha, or anti-bgal antibodies
(Promega). For binding assays with GST fusions (GST-pulldown
assays), see ref. 30 and the legend to Fig. 1E.
Cell Cycle Analysis. Flow cytometric DNA analysis was performed
as described previously (34). Briefly, exponentially growing cells
(OD600 ’1.0) were fixed in 70% ethanol and treated with RNase
A (2 mgyml) at 37°C for 2 h. Cells were then stained with
propidium iodide (50 mgyml) and analyzed by using Becton
Dickinson FACScan. Cells (’2 3 104) were analyzed in each
sample. For analyses of synchronous cultures, cells were grown
to OD600 of ’1.0 and treated with a factor (5 mgyml) for 2 h,
then washed and resuspended in yeastypeptoneydextrose (YPD
medium). Light microscopic determination of the fraction of
budded cells was carried out with samples taken after 2-h G1
arrest and at 20-min intervals after release from arrest, with
’200 cells analyzed from each sample. Synchronized cultures
were also characterized by flow cytometry.
Results
RPN4 Is Required for Normal Expression of Proteasome Components.
We initially attempted to identify S. cerevisiae RPN4-binding
proteins by using the yeast two-hybrid assay and observed that
RPN4 functioned as a transcriptional activator when fused to the
DNA-binding domain of GAL4 (data not shown). This result
was consistent with the finding that RPN4 binds to a DNA
sequence motif present in the promoters of most genes encoding
proteasomal subunits and several other genes of the Ubypro-
teasome system (28). We then examined the levels of two 26S
proteasomal subunits, RPN1 (of the 19S particle) and PRE6 (of
the 20S core proteasome) in the presence and absence of RPN4,
by using immunoblotting (Fig. 1 A and B). C-terminally epitope-
tagged RPN1-flag and PRE6-flag were expressed from their
own promoters on a low-copy vector. The levels of RPN1-flag
and PRE6-flag were significantly lower in a rpn4D strain than in
a congenic wild-type strain (Fig. 1 A and B, lanes 2 and 3). Taken
together with the gene expression data (28), these results
indicated that RPN4 is a positive transcriptional regulator of
genes encoding proteasomal subunits.
RPN4 Is a Short-Lived Protein Degraded by the 26S Proteasome.
RPN4 was expressed from the copper-inducible PCUP1 promoter
on a low-copy vector in the rpn4D strain that also expressed
RPN1-flag from its natural promoter. The expression of RPN4
from uninduced PCUP1 was sufficient to greatly augment the
expression of RPN1-flag, but further enhancement of RPN4
expression elevated the level of RPN1-flag only slightly (Fig. 1C,
lanes 3–7). In agreement with this result, a strongly increased
expression of RPN4 in the wild-type (RPN4) background re-
sulted in at most a slight enhancement of proteasome activity, as
Fig. 1. RPN4 is required for normal expression of proteasomal subunits. (A
and B) Immunoblot analysis of RPN1 (A) and PRE6 (B) that were C-terminally
tagged with flag epitope and expressed from their native promoters and a
low-copy plasmid in a rpn4D S. cerevisiae strain (lane 2) and its congenic
wild-type counterpart JD52 (lane 3). Lane 1 in A and B, cells transformed with
empty vector. (C) Enhanced expression of RPN4 marginally elevates the level
of RPN1. rpn4D cells were cotransformed with low-copy plasmids expressing,
respectively, RPN1-flag and RPN4 from the PCUP1 promoter. Increasing con-
centrations of CuSO4 were used to induce the expression of RPN4 (lanes 3–7).
Lanes 1 and 2 in C, rpn4D cells transformed, respectively, with empty RPN1-flag
vector and empty RPN4 vector. (D) Immunoblot analyses of C-terminally
(RPN4-flag) or N-terminally (ha-RPN4) tagged RPN4 that was expressed from
the induced PCUP1 promoter and low-copy plasmid either in wild-type (RPN4)
strain JD52 or in AVY302, a congenic rpn2D mutant (see legend to Fig. 2 for
details). (E) RPN4 interacts with RPN2 in GST-pulldown assays. Extracts of E. coli
expressing RPN4-flag were incubated with glutathione-agarose beads pre-
loaded with the indicated GST fusions or GST alone. The retained proteins
were eluted, fractionated, and immunoblotted with anti-FLAG antibody.
Approximately equal amounts of different GST fusions were immobilized on
glutathione-agarose beads in these assays, as verified by Coomassie staining
(data not shown). SDSyPAGE in 6, 8, and 12% gels was used, respectively, in
A and C, in D and E, and in B. The asterisk in A, C, and D indicates a crossreacting
band.
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assessed by measuring the steady-state levels of test substrates
that are targeted by either the N-end rule pathway or the UFD
pathway (data not shown), both pathways being Ubyprotea-
some-dependent (3, 35). By contrast, expression of RPN4 in
rpn4D cells greatly increased the activity of these proteolytic
pathways (data not shown).
Given these results, we expressed either a C-terminally tagged
RPN4-flag or an N-terminally tagged ha-RPN4 from the PCUP1
promoter and determined the levels of RPN4 protein at different
concentrations of the promoter-inducing CuSO4. Neither of
these tagged derivatives of RPN4 could be detected by immu-
noblotting even on the induction of PCUP1 (Fig. 1D), suggesting
that RPN4 was a short-lived protein, a property that could
account for the relative insensitivity of RPN4-dependent pro-
moters to the level of transcriptional activity of an RPN4-
expressing gene. Pulse–chase assays were then carried out with
RPN4-flag in wild-type (RPN4) cells, revealing that the in vivo
half-life of RPN4-flag was ’2 min (Fig. 2 A and D). The half-life
of N-terminally tagged ha-RPN4 was indistinguishable from that
of C-terminally tagged RPN4-flag (data not shown), ruling out
the epitope tags as the cause of RPN4 metabolic instability. S.
cerevisiae cells lacking RPN2, a protein of the 19S component of
the 26S proteasome, are partially defective in the degradation of
natural substrates of the proteasome (36) (see also the legend to
Fig. 2). Both RPN4-flag and ha-RPN4 could be detected by
immunoblotting in rpn2D cells, in contrast to wild-type (RPN2)
cells (Fig. 1D). Consistent with these results, pulse–chase assays
indicated a significant decrease in degradation of RPN4-flag in
rpn2D cells, in comparison to wild-type cells (Fig. 2 B and D). In
addition, RPN4-flag was found to be long-lived in the cim5–1
mutant (Fig. 2 C and D), which bears a ts mutation in RPT1, an
essential ATPase of the 19S particle (29). We conclude that the
in vivo degradation of RPN4 is mediated by the 26S proteasome.
RPN4 Interacts with RPN2, a Component of the 19S Particle. It was
reported that RPN4 cofractionated with the 26S proteasome
(27), but RPN4 was not observed in other studies of purified 26S
proteasomes (23, 26). Previous work (30) used the GST-
pulldown assay to demonstrate that UBR1 and UFD4, the Ub
ligase (E3) components of, respectively, the N-end rule and UFD
pathways, directly interact with specific subunits of the protea-
some’s 19S particle. We used the GST-pulldown approach to
determine whether RPN4 might interact with specific subunits of
the 19S particle. In these experiments, several proteins of the 19S
particle were expressed in E. coli as fusions to the C terminus of
GST. Extracts from E. coli expressing RPN4-flag were incubated
with glutathione-agarose beads preloaded with GST-RPN1,
GST-RPN2, GST-RPN9, GST-RPN10, GST-RPN12, or GST
alone. The bound proteins were eluted, fractionated by
SDSyPAGE, and immunoblotted with anti-f lag antibody.
RPN4-flag reproducibly bound to GST-RPN2 but not to any of
the other tested subunits of the 19S particle (Fig. 1E). It remains
to be determined whether RPN2 is the only proteasomal ligand
of RPN4, or whether some other proteasomal subunits, among
the still untested ones, also interact with RPN4.
Because the steady-state level of RPN4 in wild-type cells was
sufficiently low to be undetectable by standard immunoblotting
(Fig. 1D), RPN4 cannot be a stoichiometric component of the
19S particle. Furthermore, because RPN4 is also a transcrip-
tional regulator (28), it is clear that the population of RPN4
molecules in a cell is dynamically partitioned among several
classes of physiologically relevant complexes that include the 26S
proteasome and either specific or nonspecific RPN4-binding
sites on the chromosomes.
Is Degradation of RPN4 Ubiquitin-Dependent? As demonstrated
above (Figs. 1D and 2), RPN4 is degraded by the 26S protea-
some. Several lines of evidence suggested that ubiquitylation
plays at most a minor role in the proteasome-dependent degra-
dation of RPN4. First, the ’2-min half-life of RPN4 in wild-type
cells (Fig. 2D) was not significantly changed in the uba1–2
mutant, which underexpresses the Ub-activating (E1) enzyme
and is therefore strongly impaired in ubiquitylation of proteins
(37). Specifically, whereas the degradation of Arg-bgal, a sub-
strate of the Ub-dependent N-end rule pathway (14, 38), was
decreased in the uba1–2 mutant, no significant change was
observed with RPN4-flag in this mutant (Fig. 2E). Second,
overexpression of UbK48R,G76A, a Ub mutant that inhibits the
formation of Lys48-linked multi-Ub chains, which are essential
for a large fraction of the proteasome-dependent proteolysis (33,
39), did not significantly decrease the rate of RPN4 degradation
but did decrease the degradation of Arg-bgal (Fig. 2F). Third,
the kinetics of degradation of RPN4-flag in wild-type cells were
indistinguishable from that in mutants lacking one of the fol-
lowing Ub-conjugating (E2) enzymes: UBC1, RAD6 (UBC2),
CDC34 (UBC3), UBC4, UBC5, UBC6, UBC7, or UBC8 (data
not shown). Analogous pulse–chase assays were also carried out
with mutants lacking different pairs of these E2 enzymes. The
degradation of RPN4 was slightly decreased in [ubc4D ubc5D]
cells, which lacked UBC4 and UBC5, two highly similar E2s
(data not shown). Because UBC4yUBC5 are a functionally
major class of E2 enzymes in S. cerevisiae (7), and because [ubc4D
ubc5D] cells grow slowly and exhibit a number of defects, the
observed marginal stabilization of RPN4 in a [ubc4D ubc5D]
strain could be an indirect result of multiple changes that are
caused by the absence of UBC4yUBC5. Fourth, the degradation
of RPN4 was not decreased in S. cerevisiae mutants that lacked
Fig. 2. RPN4 is a short-lived protein degraded by a proteasome-dependent
pathway. (A–C) Pulse–chase analysis of C-terminally tagged RPN4 (RPN4-flag)
that was expressed from the induced PCUP1 promoter and low-copy plasmid
either in wild-type (RPN4) strain JD52 (A), in a congenic rpn2D mutant (B), or
in a cim5–1 mutant (C). Cells were labeled at 28°C and chased at 28°C in A and
B, and at 37°C in C. The kinetics of RPN4 degradation in JD52 were similar at
28 and 37°C (data not shown). Arrowheads indicate the band of RPN4-flag. (D)
Quantitation of the patterns in A–C, by using PhosphorImager (Molecular
Dynamics) F, wild-type cells. E, rpn2D cells. , cim5–1 cells. (E) Pulse–chase
analyses of Arg-bgal (R-bgal), derived from Ub-Arg-bgal (3, 14), and of RPN4-
flag (expressed as in A) in uba1–2 (37) and wild-type cells. Quantitation:F and
E, Arg-bgal in wild-type and uba1–2 cells, respectively.  and , RPN4-flag in
the same strains. (F) The same test proteins in wild-type cells and cells over-
expressing UbK48R, G76A, with quantitation on the right; same designations. The
rpn2D locus, in the strain AVY302 (see Materials and Methods), was a disrup-
tion allele. It was produced through the integration of URA3 at the HindIII site
of RPN2 (codon 146) and was identical to the rpn2::URA3 allele described by
Yokota et al. (36). The phenotypes of AVY302 and the previously described
strain (36) were similar as well (data not shown). Two other studies reported
that rpn2D cells were inviable (4, 56). The disruption of RPN2 in these works
was carried out with either TRP1 or ADE2, by using the RPN2 BglII site at codon
38. It remains to be determined whether different integration sites account
for different phenotypes described for rpn2D strains.
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one of the following E3 enzymes: UBR1, UFD4, RSP5, TOM1,
HUL4, or HUL5 (data not shown) (3, 14, 40, 41). Thus, it
appears, but remains to be established definitively, that the
proteasome-dependent degradation of RPN4 (Fig. 2 A and
D) is either largely or completely independent of RPN4
ubiquitylation.
N-Terminal Region of RPN4 Contains a Portable Degron. The degra-
dation signals of transcriptional activators are often located
within their activation domains (42–45). We constructed a set of
truncated, C-terminally tagged RPN4 derivatives that contained
either two, one, or none of the putative transcription-activation
domains of the intact RPN4 (Fig. 3A). Whereas wild-type RPN4
was undetectable by immunoblotting, because of its rapid in vivo
degradation (Figs. 1D and 2 A and D), RPN4 derivatives such as
RPN4206–531, RPN4314–531, and RPN4417–531, which lacked at
least the first 205 residues of RPN4, were readily detectable (Fig.
3B, lanes 5–8). By contrast, similarly expressed truncated deriv-
atives that retained this N-terminal region of RPN4 (RPN41–414,
RPN41–315, RPN41–229, and RPN41–151) were still largely unde-
tectable by immunoblotting (Fig. 3B, lanes 1–4), consistent with
the interpretation that the major degron of RPN4 was located
within its first 150–200 residues. This region does not contain
putative transcription-activation domains (Fig. 3A).
Pulse–chase assays with RPN41–151-f lag (containing the pre-
sumed degron of RPN4) and RPN4206–531-f lag (lacking this
degron) confirmed the inferences from immunoblotting data:
RPN41–151-f lag was rapidly degraded (t1/2 ’2 min), whereas
RPN4206–531-f lag was long-lived (Fig. 3C). The degron of RPN4
is portable, in that ligation of RPN41–151 to the otherwise
long-lived 115-kDa bgal moiety resulted in a metabolically
unstable RPN41–151-bgal protein (t1/2 ’5 min) (Fig. 3D). No
sequence similarities between the 151-residue region of RPN4
and the known motifs that act as degrons in other short-lived
proteins (13) could be detected, suggesting that this region of
RPN4 contains a degradation signal which, to our knowledge, is
novel. Interestingly, the C-terminally truncated, degron-
containing, metabolically unstable RPN41–229 did not bind to
RPN2 of the 19S particle in the GST-pulldown assay (data not
shown), in contrast to full-length RPN4 (Fig. 1E), suggesting that
the in vivo degradation of intact RPN4 (t1/2 ’2 min) may be
independent of the demonstrated RPN4–RPN2 interaction.
Cells Lacking RPN4 Exhibit Delay in Post-G1 Phases of the Cell Cycle.
Despite the decreased expression of proteasomal components in
rpn4D cells (Fig. 1), they were not only viable but also similar to
congenic wild-type cells in their resistance to ’260-nm UV light
and in their ability to grow at high temperature (37°C), on poor
nitrogen sources (proline and citrulline), and in the presence of
canavanine (a toxic arginine analog, at 1.5 mgyml), NaCl (at 1
M), CuSO4 (at 0.5 mM), or ethanol (at 3%) (data not shown).
At the same time, rpn4D cells are known to grow more slowly at
30°C on standard media than wild-type cells [(2–4); unpublished
data]. To assess the effect of RPN4 absence on cell cycle
progression, we carried out flow cytometric analyses of DNA
content with unsynchronized exponentially growing cultures of
haploid rpn4D and congenic wild-type cells. The fraction of cells
with 2N (replicated) DNA content was significantly higher in
rpn4D culture (Fig. 4A). Light microscopic examination indi-
cated a significantly higher fraction of budded (post-G1) cells in
exponentially growing rpn4D cultures, in comparison to wild-
type ones (data not shown), suggesting that cells lacking RPN4
are delayed in their progression through one or more of post-G1
phases of the cell cycle.
To address this question in greater detail, rpn4D and congenic
wild-type cultures were synchronized in G1 phase with a factor,
followed by flow cytometric analysis of cellular DNA content as
a function of time after release from G1 arrest. As shown in Fig.
4B, rpn4D cells exited G1 phase without delay relative to
wild-type cells. However, it took longer for rpn4D cells to
progress through the rest of the cell cycle (Fig. 4B). Light
microscopy was used to determine the fraction of budded
(post-G1) cells in synchronized cultures at different times after
resumption of growth. Consistent with the results of f low
cytometric analysis, the budding of rpn4D and wild-type cells
occurred at approximately the same time (peak at ’80 min) (Fig.
4C). However, it took longer, on average, for the budded rpn4D
cells to complete cell division (’140 min for rpn4D cells versus
’120 min for wild-type cells). Note also that a smaller fraction
of budded cells exited from M to G1 in the rpn4D culture than
in the wild-type culture (Fig. 4C), consistent with the data for
unsynchronized cultures (Fig. 4A). Because the ratio of small- to
large-budded cells was essentially the same for the synchronized
wild-type and rpn4D cultures at different time points (data not
shown), it is likely that the absence of RPN4 affects more than
one post-G1 step, e.g., both the S3 G2 and G23M transitions.
Discussion
RPN4 was originally identified as an extragenic suppressor of
sec63-101, a ts allele of SEC63, which is required for the
translocation of proteins into the endoplasmic reticulum and the
transport of proteins to the nucleus (2). rpn4 mutations sup-
pressed the ts growth defect of sec63-101 but did not reverse its
phenotype of mislocalization of proteins that bore a nuclear
targeting signal. Moreover, rpn4 mutants themselves had a
Fig. 3. The N-terminal region of RPN4 contains a portable degradation
signal. (A) Diagrams of full-length and truncated RPN4. Two putative tran-
scription activation domains are at positions 211–229 and 300–315 (hatched
boxes). A putative bipartite nuclear localization signal is at position 381–399
(black box). A putative C2H2 finger (residues 477–507) is also indicated. (B)
N-terminally truncated RPN4 derivatives are long-lived. RPN4 and its trun-
cated derivatives were expressed from the PCUP1 promoter and low-copy
vector in the JD52 (RPN4) strain. Relative steady-state levels of truncated RPN4
proteins (all of them tagged C-terminally with flag epitope) were determined
by immunoblotting, by using SDSy12% PAGE and anti-flag antibody. The
bands of proteins with expected sizes are indicated by arrowheads. (C)
RPN41–151-flag is short-lived. Pulse–chase assays, by using SDSy12% PAGE,
were carried out in wild-type (RPN4) cells with RPN4206 –531-flag and
RPN41–151-flag (indicated by arrowheads) essentially as described in Fig. 2,
except that they were performed at 30°C instead of 28°C. (D) The 151-residue
N-terminal fragment of RPN4 contains a portable degron. Pulse–chase assay
with RPN41–151-bgal fusion (see Materials and Methods) expressed from the
PCUP1 promoter and low-copy vector in the JD52 (RPN4) strain, by using
SDSy6% PAGE and immunoprecipitation with anti-bgal antibody.
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defect in the nuclear protein import (2). Later work has shown
that mutations in RPN4 inhibit the activity of the Ubyprotea-
some-dependent N-end rule and UFD proteolytic pathways (3).
Our findings (Fig. 1 A and B) and a recent study (28) demon-
strated that RPN4 is required for normal expression of subunits
of the 26S proteasome and several other components of the Ub
system. A parsimonious interpretation is that the observed
down-regulation of the Ubyproteasome-dependent proteolysis
in rpn4D cells results primarily from decreased expression of
proteasomal subunits and functionally related proteins.
Previous studies did not reach a consensus on whether RPN4
is a component of the 26S proteasome (23, 24, 26, 27). A direct
and specific interaction between RPN2 (a stoichiometric subunit
of the 19S particle) and RPN4 was demonstrated in the present
work (Fig. 1E). This result, together with the earlier finding that
the E3 enzymes UBR1 and UFD4 interact with specific subunits
of the 19S particle (30) and the evidence for interactions between
other E2yE3 enzymes and the 26S proteasome (23, 46), indicates
that proteasome is at least a transient ligand of many cellular
proteins.
An operationally useful definition of a bona fide subunit of the
26S proteasome should stipulate that a large (predetermined)
fraction of the proteasome particles in a cell is associated with
this subunit in vivo. By contrast, and similarly to terminology in
the ribosome field, specific protein ligands of the proteasome
that interact with it transiently andyor are bound to small,
dynamically determined subsets of the 26S proteasome, can be
called proteasome-interacting proteins. In this terminology,
RPN4, UBR1, and UFD4 are proteasome-interacting proteins,
as distinguished from the 26S proteasomal subunits such as
PRE6, RPT6, or RPN2.
RPN4 is not essential for cell viability under normal condi-
tions. As described above, rpn4D cells are not hypersensitive to
a variety of physical and chemical stresses, suggesting that a
strongly decreased concentration of the 26S proteasome in
rpn4D cells is sufficient to maintain cell viability and growth even
under conditions of stress. At the same time, given the dimin-
ished activity of at least the N-end rule and UFD pathways in
rpn4D cells (3), one would expect an impairment of some
physiological functions that require these pathways. The post-G1
abnormality in the cell cycle progression of rpn4D cells described
in the present work (Fig. 4) is unlikely to be caused by inhibition
of the N-end rule pathway, because ubr1D cells, which lack this
pathway, lose chromosomes at a greatly increased frequency but
are similar to congenic wild-type cells in the kinetics of cell cycle
progression (47). [The chromosome-loss phenotype of ubr1D
cells is caused largely by metabolic stabilization of the ESP1-
produced fragment of SCC1, a prosubstrate of the N-end rule
pathway and a component of the chromosome-bound cohesin
complex (47).] Because RPN4 functions as a transcriptional
activator of many nonproteasomal genes as well (48), the cell
cycle defect of rpn4D cells may stem from down-regulation of
these other genes. For example, the expression of CDC48, which
is essential for the cell cycle progression and encodes an AAA-
type ATPase, is decreased in rpn4D cells (28). However, we
found that overexpression of CDC48 from a heterologous
(PMET25) promoter did not rescue the cell cycle abnormality of
rpn4D cells (data not shown).
One of our main results is the striking metabolic instability of
RPN4 (t1/2 ’2 min). The degradation of RPN4 is proteasome-
dependent (Fig. 2 A–D). At the same time, several lines of
evidence (Fig. 2 E and F; see also above) suggest that degrada-
tion of RPN4 is largely independent of ubiquitylation. Proteins
whose in vivo degradation is proteasome-dependent but Ub-
independent include ornithine decarboxylase (49) and the cy-
clin-dependent kinase inhibitor p21Cip1 (50, 51).
The mapping of RPN4 degron localized it to the first 150
residues of the 531-residue RPN4 (Fig. 3), outside of its putative
transcription activation domains. This location of a degron is an
exception to the previously established pattern in which the
activation domains and degrons tend to overlap in a transcrip-
tional regulator (42–45). As to the mechanics of RPN4 degron,
the properties of RPN4 suggest two possibilities. The N-terminal
degradation signal of RPN4 may function as a canonical bipartite
degron of the Ubyproteasome system (12, 13, 52). The first
determinant of such a degron is bound by a degron-specific
E2-E3 Ub ligase, whereas the second determinant is an internal
Lys residue of a substrate protein. Alternatively, RPN4 might be
targeted for degradation directly through its demonstrated in-
teraction with RPN2, a subunit of the 19S particle (Fig. 1E). This
model is made unlikely (but not definitively precluded) by the
fact that the degron-containing, short-lived RPN41–229 fragment
was unable to bind to RPN2, in contrast to full-length RPN4 (see
above).
Metabolic instability of RPN4 identifies it as a member of a
growing class of components of the Ubyproteasome system that
are also substrates of this system and are destroyed by it, either
constitutively or conditionally. One example is UMP1, a chap-
erone that is required for efficient assembly of the 20S protea-
some and becomes its first substrate on the completion of
assembly (22, 53). Other examples are S. cerevisiae F-box pro-
teins CDC4, GRR1, and MET30, which are short-lived sub-
strate-recognition subunits of, respectively, SCFCdc4, SCFGrr1,
and SCFMet30 Ub ligases (54, 55).
The unique ability of RPN4 to augment the transcription of
genes encoding proteasomal subunits while being metabolically
unstable yields a negative feedback circuit in which the same
protein up-regulates the proteasome production and is destroyed
by the assembled active proteasome.
Fig. 4. Cell cycle progression is delayed after G1 phase in rpn4D mutant. (A)
A larger fraction of rpn4D cells have 2N DNA content in unsynchronized
cultures. DNA flow cytometry was carried out with wild-type (RPN4) and
rpn4D cells. The abscissa ordinate indicate, respectively, the number of cells
and relative DNA content. (B and C) Cell cycle progression of rpn4D cells is
delayed after G1 phase. Wild-type and congenic rpn4D cells were synchronized
in late G1 by using a factor. Initial samples were taken after 2 h of G1 arrest, and
subsequent samples were taken at 20-min intervals after release from the
arrest. The samples were analyzed by using DNA flow cytometry (B) and by
determining the fraction of budded cells (C). Data shown in C are the means
of triplicate measurements.
3060 u www.pnas.orgycgiydoiy10.1073ypnas.071022298 Xie and Varshavsky
We are grateful to Xiaofeng Qin and Wenge Lu for advice and
assistance with f low cytometric analysis, to Christopher Byrd (Cali-
fornia Institute of Technology), Ju¨rgen Dohmen (University of Co-
logne, Cologne, Germany), Mark Hochstrasser (Yale University, New
Haven, CT), Jon Huibregtse (Rutgers University, Piscataway, NJ),
Erica Johnson (Thomas Jefferson University, Philadelphia, PA),
Yoshiko Kikuchi (University of Tokyo, Tokyo, Japan), Robert Swan-
son (University of Chicago, Chicago, IL), Glenn Turner (California
Institute of Technology), and Fred Winston (Harvard Medical School,
Boston, MA) for strains and constructs, and to Keiji Tanaka (Institute
of Medical Science, Tokyo) for anti-RPN4 antibody. This work was
supported by grants to A.V. from the National Institutes of Health
(NIH) (DK39520 and GM31530). Y.X. was supported in part by a
postdoctoral fellowship from the NIH.
1. Finley, D., Tanaka, K., Mann, C., Feldmann, H., Hochstrasser, M., Vierstra, R.,
Johnston, S., Hampton, R., Haber, J., McCusker, J., et al (1998) Trends
Biochem. Sci. 23, 244–245.
2. Nelson, M. K., Kurihara, T. & Silver, P. A. (1993) Genetics 134, 159–173.
3. Johnson, E. S., Ma, P. C., Ota, I. M. & Varshavsky, A. (1995) J. Biol. Chem.
270, 17442–17456.
4. Xu, B.-E. & Kurjan, J. (1997) Mol. Biol. Cell 8, 1649–1664.
5. Hershko, A., Ciechanover, A. & Varshavsky, A. (2000) Nat. Med. 10, 1073–
1081.
6. Varshavsky, A. (1997) Trends Biochem. Sci. 22, 383–387.
7. Hochstrasser, M. (1996) Annu. Rev. Genet. 30, 405–439.
8. Scheffner, M., Smith, S. & Jentsch, S. (1998) in Ubiquitin and the Biology of the Cell,
eds. Peters, J.-M., Harris, J. R. & Finley, D. (Plenum, New York), pp. 65–98.
9. Deshaies, R. J. (1999) Annu. Rev. Cell Dev. Biol. 15, 435–467.
10. Tyers, M. & Jorgensen, P. (2000) Curr. Opin. Genet. Dev. 10, 54–64.
11. Schulman, B. A., Carrano, A. C., Jeffrey, P. D., Bowen, Z., Kinnucan, E. R. E.,
Finnin, M. S., Elledge, S. J., Harper, J. W., Pagano, M. & Pavletich, N. (2000)
Nature (London) 408, 381–386.
12. Dohmen, R. J. (2000) in Proteasomes: The World of Regulatory Proteolysis, eds.
Hilt, W. & Wolf, D. (Landes, Georgetown, TX), pp. 188–205.
13. Laney, J. D. & Hochstrasser, M. (1999) Cell 97, 427–430.
14. Varshavsky, A. (1996) Proc. Natl. Acad. Sci. USA 93, 12142–12149.
15. Pickart, C. M. (1997) FASEB J. 11, 1055–1066.
16. Dubiel, W. & Gordon, C. (1999) Curr. Biol. 9, 554–557.
17. Voges, D., Zwickl, P. & Baumeister, W. (1999) Annu. Rev. Biochem. 68,
1015–1068.
18. DeMartino, G. N. & Slaughter, C. A. (1999) J. Biol. Chem. 274, 22123–22126.
19. Rechsteiner, M. (1998) in Ubiquitin and the Biology of the Cell, eds. Peters, J. M.,
Harris, J. R. & Finley, D. (Plenum, New York), pp. 147–189.
20. Hendil, K. B., Khan, S. & Tanaka, K. (1998) Biochem. J. 332, 749–754.
21. Whitby, F. G., Masters, E. I., Kramer, L., Knowlton, J. R., Yao, Y., Wang, C. C.
& Hill, C. P. (2000) Nature (London) 408, 115–120.
22. Ramos, P. C., Ho¨ckendorff, J., Johnson, E. S., Varshavsky, A. & Dohmen, R. J.
(1998) Cell 92, 489–499.
23. Verma, R., Chen, S., Feldman, R., Schieltz, D., Yates, J., Dohmen, R. J. &
Deshaies, R. J. (2000) Mol. Biol. Cell 11, 3425–3439.
24. Russell, S. J., Steger, K. A. & Johnston, S. A. (1999) J. Biol. Chem. 274,
21943–21952.
25. Glickman, M. H., Rubin, D. M., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z.,
Baumeister, W., Fried, V. A. & Finley, D. (1998) Cell 94, 615–623.
26. Glickman, M. H., Rubin, D. M., Fried, V. A. & Finley, D. (1998) Mol. Cell. Biol.
18, 3149–3162.
27. Fujimoro, M., Tanaka, K., Yokosawa, H. & Toh-e, A. (1998) FEBS Lett. 423,
149–154.
28. Mannhaupt, G., Schnall, R., Karpov, V., Vetter, I. & Feldmann, H. (1999)
FEBS Lett. 450, 27–34.
29. Ghislain, M., Udvardy, A. & Mann, C. (1993) Nature (London) 366, 358–362.
30. Xie, Y. & Varshavsky, A. (2000) Proc. Natl. Acad. Sci. USA 97, 2497–2502.
(First Published February 25, 2000; 10.1073ypnas.060025497)
31. Sikorski, R. S. & Hieter, P. (1989) Genetics 122, 19–27.
32. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Smith, J. A., Seidman,
J. G. & Struhl, K. (1998) Current Protocols in Molecular Biology (Wiley, New
York).
33. Finley, D., Sadis, S., Monia, B. P., Boucher, P., Ecker, D. J., Crooke, S. T. &
Chau, V. (1994) Mol. Cell. Biol. 14, 5501–5509.
34. Haase, S. & Lew, D. J. (1997) Methods Enzymol. 283, 322–332.
35. Baker, R. T. & Varshavsky, A. (1991) Proc. Natl. Acad. Sci. USA 87, 2374–2378.
36. Yokota, K., Kagawa, S., Shimizu, Y., Akioka, H., Tsurumi, C., Noda, C.,
Fujimuro, M., Yokosawa, H., Fujiwara, T., Takahashi, E., et al. (1996) Mol.
Biol. Cell 7, 853–870.
37. Swanson, R. & Hochstrasser, M. (2000) FEBS Lett. 477, 193–198.
38. Kwon, Y. T., Balogh, S. A., Davydov, I. V., Kashina, A. S., Yoon, J. K., Xie,
Y., Gaur, A., Hyde, L., Denenberg, V. H. & Varshavsky, A. (2000) Mol. Cell.
Biol. 20, 4135–4148.
39. Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K.
& Varshavsky, A. (1989) Science 243, 1576–1583.
40. Wang, G., Yang, J. & Huibregtse, J. M. (1999) Mol. Cell. Biol. 19, 342–352.
41. Sasaki, T., Toh-e, A. & Kikuchi, Y. (2000) Mol. Gen. Genet. 262, 940–948.
42. Flinn, E. M., Busch, C. M. C. & Wright, A. P. H. (1998) Mol. Cell. Biol. 18,
5961–5969.
43. Molinari, E., Gilman, M. & Natesan, S. (1999) EMBO J. 22, 6439–6447.
44. Wang, D., Moriggl, R., Stravopodis, D., Carpino, N., Marine, J.-C., Teglund,
S., Feng, J. & Ihle, J. N. (2000) EMBO J. 19, 392–399.
45. Salghetti, S. E., Muratani, M., Wijnen, H., Futcher, B. & Tansey, W. P. (2000)
Proc. Natl. Acad. Sci. USA 97, 3118–3123. (First Published March 7, 2000;
10.1073ypnas.050007597)
46. Tongaonkar, P., Chen, L., Lambertson, D., Ko, B. & Madura, K. (2000) Mol.
Cell. Biol. 20, 4691–4698.
47. Rao, H., Uhlmann, F., Nasmyth, K. & Varshavsky, A. (2001) Nature (London)
(in press).
48. Jelinsky, S. A., Estep, P., Church, G. M. & Samson, L. D. (2000) Mol. Cell. Biol.
20, 8157–8167.
49. Coffino, P. (1998) in Ubiquitin and the Biology of the Cell, eds. Peters, J. M.,
Harris, J. R. & Finley, D. (Plenum, New York), pp. 411–428.
50. Sheaff, R. J., Singer, J. D., Swanger, J., Smitherman, M., Roberts, J. M. &
Clurman, B. E. (2000) Mol. Cell 5, 403–410.
51. Verma, R. & Deshaies, R. J. (2000) Cell 101, 341–344.
52. Bachmair, A. & Varshavsky, A. (1989) Cell 56, 1019–1032.
53. Burri, L., Ho¨ckendorff, J., Boehm, U., Klamp, T., Dohmen, R. J. & Le´vy, F.
(2000) Proc. Natl. Acad. Sci. USA 97, 10348–10353. (First Published September
5, 2000; 10.1073ypnas.190268597)
54. Zhou, P. & Howley, P. M. (1998) Mol. Cell 2, 571–580.
55. Rouillon, A., Barbey, R., Patton, E., Tyers, M. & Thomas, D. (2000) EMBO J.
19, 282–294.
56. DeMarini, D. J., Papa, F. R., Swaminathan, S., Ursic, D., Rasmussen, T. P.,
Culbertson, M. R. & Hochstrasser, M. (1995) Mol. Cell. Biol. 15, 6311–6321.
Xie and Varshavsky PNAS u March 13, 2001 u vol. 98 u no. 6 u 3061
BI
O
CH
EM
IS
TR
Y
